Keywords
Last Name
Institution

Juan J. Badimon

TitlePROFESSOR
InstitutionMount Sinai
DepartmentCardiology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Zhao S, Nishimura T, Chen Y, Azeloglu EU, Gottesman O, Giannarelli C, Zafar MU, Benard L, Badimon JJ, Hajjar RJ, Goldfarb J, Iyengar R. Systems pharmacology of adverse event mitigation by drug combinations. Sci Transl Med. 2013 Oct 9; 5(206):206ra140.
      View in: PubMed
    2. Hutter R, Huang L, Speidl WS, Giannarelli C, Trubin P, Bauriedel G, Klotman ME, Fuster V, Badimon JJ, Klotman PE. Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation. 2013 Nov 26; 128(22):2351-63.
      View in: PubMed
    3. Baber U, Bander J, Karajgikar R, Yadav K, Hadi A, Theodoropolous K, Gukathasan N, Roy S, Sayeneni S, Scott SA, Kovacic JC, Yu J, Sartori S, Mehran R, Uribarri J, Badimon JJ, Muntner P, Moreno P, Kini AS, Sharma SK. Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivity. Thromb Haemost. 2013 Jul; 110(1):118-23.
      View in: PubMed
    4. Hutter R, Speidl WS, Valdiviezo C, Sauter B, Corti R, Fuster V, Badimon JJ. Macrophages transmit potent proangiogenic effects of oxLDL in vitro and in vivo involving HIF-1a activation: a novel aspect of angiogenesis in atherosclerosis. J Cardiovasc Transl Res. 2013 Aug; 6(4):558-69.
      View in: PubMed
    5. Guillot N, Kollins D, Badimon JJ, Schlondorff D, Hutter R. Accelerated reendothelialization, increased neovascularization and erythrocyte extravasation after arterial injury in BAMBI-/- mice. PLoS One. 2013; 8(3):e58550.
      View in: PubMed
    6. Zafar MU, Santos-Gallego C, Vorchheimer DA, Viles-Gonzalez JF, Elmariah S, Giannarelli C, Sartori S, Small DS, Jakubowski JA, Fuster V, Badimon JJ. Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation. J Thromb Haemost. 2013 Jan; 11(1):100-6.
      View in: PubMed
    7. Becker EM, Perzborn E, Klipp A, Lücker C, Bütehorn U, Kast R, Badimon JJ, Laux V. Effects of rivaroxaban, acetylsalicylic acid and clopidogrel as monotherapy and in combination in a porcine model of stent thrombosis. J Thromb Haemost. 2012 Dec; 10(12):2470-80.
      View in: PubMed
    8. Giannarelli C, Cimmino G, Ibanez B, Chiesa G, Garcia-Prieto J, Santos-Gallego CG, Alique-Aguilar M, Fuster V, Sirtori C, Badimon JJ. Acute ApoA-I Milano administration induces plaque regression and stabilisation in the long term. Thromb Haemost. 2012 Dec; 108(6):1246-8.
      View in: PubMed
    9. Vilahur G, Cubedo J, Casani L, Padro T, Sabate-Tenas M, Badimon JJ, Badimon L. Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway. Eur Heart J. 2013 Jul; 34(27):2082-93.
      View in: PubMed
    10. Hutter R, Badimon JJ, Fuster V, Narula J. Coronary artery disease in aging women: a menopause of endothelial progenitor cells? Med Clin North Am. 2012 Jan; 96(1):93-102.
      View in: PubMed
    11. Arazi HC, Badimon JJ. Anti-inflammatory effects of anti-platelet treatment in atherosclerosis. Curr Pharm Des. 2012; 18(28):4311-25.
      View in: PubMed
    12. Ibanez B, Giannarelli C, Cimmino G, Santos-Gallego CG, Alique M, Pinero A, Vilahur G, Fuster V, Badimon L, Badimon JJ. Recombinant HDL(Milano) exerts greater anti-inflammatory and plaque stabilizing properties than HDL(wild-type). Atherosclerosis. 2012 Jan; 220(1):72-7.
      View in: PubMed
    13. Giannarelli C, Klein RS, Badimon JJ. Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis. 2011 Dec; 219(2):384-9.
      View in: PubMed
    14. Giannarelli C, Cimmino G, Connolly TM, Ibanez B, Ruiz JM, Alique M, Zafar MU, Fuster V, Feuerstein G, Badimon JJ. Synergistic effect of liver X receptor activation and simvastatin on plaque regression and stabilization: an magnetic resonance imaging study in a model of advanced atherosclerosis. Eur Heart J. 2012 Jan; 33(2):264-73.
      View in: PubMed
    15. Ishikawa K, Ladage D, Takewa Y, Yaniz E, Chen J, Tilemann L, Sakata S, Badimon JJ, Hajjar RJ, Kawase Y. Development of a preclinical model of ischemic cardiomyopathy in swine. Am J Physiol Heart Circ Physiol. 2011 Aug; 301(2):H530-7.
      View in: PubMed
    16. Lucking AJ, Lundbäck M, Barath SL, Mills NL, Sidhu MK, Langrish JP, Boon NA, Pourazar J, Badimon JJ, Gerlofs-Nijland ME, Cassee FR, Boman C, Donaldson K, Sandstrom T, Newby DE, Blomberg A. Particle traps prevent adverse vascular and prothrombotic effects of diesel engine exhaust inhalation in men. Circulation. 2011 Apr 26; 123(16):1721-8.
      View in: PubMed
    17. Cimmino G, Giannarelli C, Chen W, Alique M, Santos-Gallego CG, Fuster V, Hajjar RJ, Walsh CE, Badimon JJ. Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration. J Cardiovasc Pharmacol. 2011 Mar; 57(3):325-33.
      View in: PubMed
    18. Angiolillo DJ, Badimon JJ, Saucedo JF, Frelinger AL, Michelson AD, Jakubowski JA, Zhu B, Ojeh CK, Baker BA, Effron MB. A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J. 2011 Apr; 32(7):838-46.
      View in: PubMed
    19. Giannarelli C, Ibanez B, Cimmino G, Garcia Ruiz JM, Faita F, Bianchini E, Zafar MU, Fuster V, Garcia MJ, Badimon JJ. Contrast-enhanced ultrasound imaging detects intraplaque neovascularization in an experimental model of atherosclerosis. JACC Cardiovasc Imaging. 2010 Dec; 3(12):1256-64.
      View in: PubMed
    20. Ibanez B, Fuster V, Jiménez-Borreguero J, Badimon JJ. Lethal myocardial reperfusion injury: a necessary evil? Int J Cardiol. 2011 Aug 18; 151(1):3-11.
      View in: PubMed
    21. Giannarelli C, Zafar MU, Badimon JJ. Prostanoid and TP-receptors in atherothrombosis: is there a role for their antagonism? Thromb Haemost. 2010 Nov; 104(5):949-54.
      View in: PubMed
    22. Cimmino G, Ibanez B, Giannarelli C, Prat-González S, Hutter R, Garcia M, Sanz J, Fuster V, Badimon JJ. Carvedilol administration in acute myocardial infarction results in stronger inhibition of early markers of left ventricular remodeling than metoprolol. Int J Cardiol. 2011 Dec 15; 153(3):256-61.
      View in: PubMed
    23. Speidl WS, Kastl SP, Hutter R, Katsaros KM, Kaun C, Bauriedel G, Maurer G, Huber K, Badimon JJ, Wojta J. The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J. 2011 Jan; 25(1):35-44.
      View in: PubMed
    24. Lucking AJ, Chelliah R, Trotman AD, Connolly TM, Feuerstein GZ, Fox KA, Boon NA, Badimon JJ, Newby DE. Characterisation and reproducibility of a human ex vivo model of thrombosis. Thromb Res. 2010 Nov; 126(5):431-5.
      View in: PubMed
    25. Cimmino G, Golino P, Badimon JJ. Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? Intern Emerg Med. 2011 Feb; 6(1):29-34.
      View in: PubMed
    26. Badimón JJ, Santos-Gallego CG, Badimón L. [Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going?]. Rev Esp Cardiol. 2010 Jun; 63 Suppl 2:20-35.
      View in: PubMed
    27. Speidl WS, Cimmino G, Ibanez B, Elmariah S, Hutter R, Garcia MJ, Fuster V, Goldman ME, Badimon JJ. Recombinant apolipoprotein A-I Milano rapidly reverses aortic valve stenosis and decreases leaflet inflammation in an experimental rabbit model. Eur Heart J. 2010 Aug; 31(16):2049-57.
      View in: PubMed
    28. Arazi HC, Doiny DG, Torcivia RS, Grancelli H, Waldman SV, Nojek C, Fornari MC, Badimon JJ. Impaired anti-platelet effect of aspirin, inflammation and platelet turnover in cardiac surgery. Interact Cardiovasc Thorac Surg. 2010 Jun; 10(6):863-7.
      View in: PubMed
    29. Badimón JJ, Ibáñez B. Increasing high-density lipoprotein as a therapeutic target in atherothrombotic disease. Rev Esp Cardiol. 2010 Mar; 63(3):323-33.
      View in: PubMed
    30. Zafar MU, Paz-Yepes M, Shimbo D, Vilahur G, Burg MM, Chaplin W, Fuster V, Davidson KW, Badimon JJ. Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression. Eur Heart J. 2010 Jul; 31(13):1573-82.
      View in: PubMed
    31. Vila PM, Zafar MU, Badimon JJ. Platelet reactivity and nonresponse to dual antiplatelet therapy: a review. Platelets. 2009 Dec; 20(8):531-8.
      View in: PubMed
    32. Ibanez B, Cimmino G, Prat-González S, Vilahur G, Hutter R, García MJ, Fuster V, Sanz J, Badimon L, Badimon JJ. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol. 2011 Mar 17; 147(3):428-32.
      View in: PubMed
    33. Cimmino G, Chen W, Speidl WS, Giannarelli C, Ibanez B, Fuster V, Hajjar R, Walsh CE, Badimon JJ. Safe and sustained overexpression of functional apolipoprotein A-I/high-density lipoprotein in apolipoprotein A-I-null mice by muscular adeno-associated viral serotype 8 vector gene transfer. J Cardiovasc Pharmacol. 2009 Nov; 54(5):405-11.
      View in: PubMed
    34. Choi BG, Vilahur G, Badimon JJ. Letter by Choi et al regarding article, "Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: results of subgroup analyses by age and other factors". Circulation. 2009 Oct 27; 120(17):e147; author reply e148.
      View in: PubMed
    35. Zafar MU, Ibáñez B, Choi BG, Vorchheimer DA, Piñero A, Jin X, Sharma RK, Badimon JJ. A new oral antiplatelet agent with potent antithrombotic properties: comparison of DZ-697b with clopidogrel a randomised phase I study. Thromb Haemost. 2010 Jan; 103(1):205-12.
      View in: PubMed
    36. Badimon JJ, Ibanez B, Cimmino G. Genesis and dynamics of atherosclerotic lesions: implications for early detection. Cerebrovasc Dis. 2009; 27 Suppl 1:38-47.
      View in: PubMed
    37. Bogdanov VY, Cimmino G, Tardos JG, Tunstead JR, Badimon JJ. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay. J Thromb Haemost. 2009 May; 7(5):894-7.
      View in: PubMed
    38. Ibañez B, Badimon JJ, Garcia MJ. Diagnosis of atherosclerosis by imaging. Am J Med. 2009 Jan; 122(1 Suppl):S15-25.
      View in: PubMed
    39. Cimmino G, Ibanez B, Vilahur G, Speidl WS, Fuster V, Badimon L, Badimon JJ. Up-regulation of reverse cholesterol transport key players and rescue from global inflammation by ApoA-I(Milano). J Cell Mol Med. 2009 Sep; 13(9B):3226-35.
      View in: PubMed
    40. Ibanez B, Badimon JJ. Cyclosporine in acute myocardial infarction. N Engl J Med. 2008 Nov 20; 359(21):2287; author reply 2288-9.
      View in: PubMed
    41. Worthley SG, Zhang ZY, Machac J, Helft G, Tang C, Liew GY, Zaman AG, Worthley MI, Fayad ZA, Buchsbaum MS, Fuster V, Badimon JJ. In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis. Int J Cardiovasc Imaging. 2009 Mar; 25(3):251-7.
      View in: PubMed
    42. Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, Cassee FR, Donaldson K, Boon NA, Badimon JJ, Sandstrom T, Blomberg A, Newby DE. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J. 2008 Dec; 29(24):3043-51.
      View in: PubMed
    43. Natarajan A, Marshall SM, Worthley SG, Badimon JJ, Zaman AG. The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus. J Thromb Haemost. 2008 Dec; 6(12):2210-3.
      View in: PubMed
    44. Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease. Thromb Haemost. 2008 Jul; 100(1):76-82.
      View in: PubMed
    45. Santos-Gallego CG, Ibanez B, Badimon JJ. HDL-cholesterol: is it really good? Differences between apoA-I and HDL. Biochem Pharmacol. 2008 Aug 15; 76(4):443-52.
      View in: PubMed
    46. Ibanez B, Cimmino G, Bénézet-Mazuecos J, Santos-Gallego CG, Pinero A, Prat-González S, Speidl WS, Fuster V, García MJ, Sanz J, Badimon JJ. Quantification of serial changes in plaque burden using multi-detector computed tomography in experimental atherosclerosis. Atherosclerosis. 2009 Jan; 202(1):185-91.
      View in: PubMed
    47. Ibanez B, Vilahur G, Cimmino G, Speidl WS, Pinero A, Choi BG, Zafar MU, Santos-Gallego CG, Krause B, Badimon L, Fuster V, Badimon JJ. Rapid change in plaque size, composition, and molecular footprint after recombinant apolipoprotein A-I Milano (ETC-216) administration: magnetic resonance imaging study in an experimental model of atherosclerosis. J Am Coll Cardiol. 2008 Mar 18; 51(11):1104-9.
      View in: PubMed
    48. Worthley SG, Helft G, Corti R, Worthley MI, Chew DP, Fayad ZA, Zaman AG, Fallon JT, Fuster V, Badimon JJ. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. Pathophysiol Haemost Thromb. 2007; 36(1):9-17.
      View in: PubMed
    49. Choi BG, Vilahur G, Zafar MU, Cardoso L, Yadegar D, Ibanez B, Tunstead J, Viles-Gonzalez JF, Schaffler MB, Fuster V, Badimon JJ. Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis. 2008 Nov; 201(1):76-84.
      View in: PubMed
    50. Choi BG, Vilahur G, Cardoso L, Fritton JC, Ibanez B, Zafar MU, Yadegar D, Speidl WS, Schaffler MB, Fuster V, Badimon JJ. Ovariectomy increases vascular calcification via the OPG/RANKL cytokine signalling pathway. Eur J Clin Invest. 2008 Apr; 38(4):211-7.
      View in: PubMed
    51. Ibanez B, Cimmino G, Badimon JJ. Myocardial reperfusion injury. N Engl J Med. 2007 Dec 6; 357(23):2409; author reply 2409-10.
      View in: PubMed
    52. Benezet-Mazuecos J, Ibanez B, Badimon JJ. Dual antiplatelet therapy and drug eluting stents: a marriage of convenience. Thromb J. 2007; 5:15.
      View in: PubMed
    53. Zafar MU, Vorchheimer DA, Gaztanaga J, Velez M, Yadegar D, Moreno PR, Kunitada S, Pagan J, Fuster V, Badimon JJ. Antithrombotic effects of factor Xa inhibition with DU-176b: Phase-I study of an oral, direct factor Xa inhibitor using an ex-vivo flow chamber. Thromb Haemost. 2007 Oct; 98(4):883-8.
      View in: PubMed
    54. Wyttenbach R, Corti R, Alerci M, Cozzi L, Di Valentino M, Segatto JM, Badimon JJ, Fuster V, Gallino A. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery: 2 years follow-up by noninvasive magnetic resonance imaging. Eur J Vasc Endovasc Surg. 2007 Oct; 34(4):416-23.
      View in: PubMed
    55. Ibanez B, Vilahur G, Badimon JJ. Plaque progression and regression in atherothrombosis. J Thromb Haemost. 2007 Jul; 5 Suppl 1:292-9.
      View in: PubMed
    56. Anand SX, Kim MC, Kamran M, Sharma SK, Kini AS, Fareed J, Hoppensteadt DA, Carbon F, Cavusoglu E, Varon D, Viles-Gonzalez JF, Badimon JJ, Marmur JD. Comparison of platelet function and morphology in patients undergoing percutaneous coronary intervention receiving bivalirudin versus unfractionated heparin versus clopidogrel pretreatment and bivalirudin. Am J Cardiol. 2007 Aug 1; 100(3):417-24.
      View in: PubMed
    57. Zafar MU, Vilahur G, Choi BG, Ibanez B, Viles-Gonzalez JF, Salas E, Badimon JJ. A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects. J Thromb Haemost. 2007 Jun; 5(6):1195-200.
      View in: PubMed
    58. Ibanez B, Prat-González S, Speidl WS, Vilahur G, Pinero A, Cimmino G, García MJ, Fuster V, Sanz J, Badimon JJ. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation. 2007 Jun 12; 115(23):2909-16.
      View in: PubMed
    59. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Lüscher TF. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med. 2007 May; 12(2):113-22.
      View in: PubMed
    60. Meerarani P, Moreno PR, Cimmino G, Badimon JJ. Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation. Indian J Exp Biol. 2007 Jan; 45(1):103-10.
      View in: PubMed
    61. Choi BG, Novoselsky CA, Vilahur G, Viles-Gonzalez JF, Zafar MU, Ibanez B, Fuster V, Badimon JJ. Validation study of a semi-automated program for quantification of atherosclerotic burden. J Cardiovasc Magn Reson. 2007; 9(3):615-20.
      View in: PubMed
    62. Davidson JA, Moreno PR, Badimon JJ, Lopez-Candales A, Maisonet Giachello AL, Ovalle F, Rodriguez CJ, Rosenson RS, Rodbard HW, Kannel WB. Cardiovascular disease prevention and care in Latino and Hispanic subjects. Endocr Pract. 2007 Jan-Feb; 13(1):77-85.
      View in: PubMed
    63. Vilahur G, Choi BG, Zafar MU, Viles-Gonzalez JF, Vorchheimer DA, Fuster V, Badimon JJ. Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost. 2007 Jan; 5(1):82-90.
      View in: PubMed
    64. Spieker LE, Flammer AJ, Amacker N, Sudano I, Badimon JJ, Ruschitzka F, Lüscher TF, Noll G, Corti R. C-reactive protein influences shear stress-dependent platelet adhesion in patients with familiar hypercholesterolemia and coronary artery disease undergoing LDL apheresis. Thromb Haemost. 2006 Oct; 96(4):540-2.
      View in: PubMed
    65. Choi BG, Vilahur G, Ibanez B, Zafar MU, Rodriguez J, Badimon JJ. Measures of thrombosis and fibrinolysis. Clin Lab Med. 2006 Sep; 26(3):655-78, vii.
      View in: PubMed
    66. Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis. Curr Mol Med. 2006 Aug; 6(5):489-99.
      View in: PubMed
    67. Meerarani P, Badimon JJ, Zias E, Fuster V, Moreno PR. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications. Curr Mol Med. 2006 Aug; 6(5):501-14.
      View in: PubMed
    68. Choi BG, Vilahur G, Yadegar D, Viles-Gonzalez JF, Badimon JJ. The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases. Curr Mol Med. 2006 Aug; 6(5):571-87.
      View in: PubMed
    69. Choi BG, Vilahur G, Viles-Gonzalez JF, Badimon JJ. The role of high-density lipoprotein cholesterol in atherothrombosis. Mt Sinai J Med. 2006 Jul; 73(4):690-701.
      View in: PubMed
    70. Liu H, Zheng F, Li Z, Uribarri J, Ren B, Hutter R, Tunstead JR, Badimon J, Striker GE, Vlassara H. Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme. Am J Pathol. 2006 Jul; 169(1):303-13.
      View in: PubMed
    71. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006 Jul 17; 98(2A):2H-15H.
      View in: PubMed
    72. Zhang Z, Machac J, Helft G, Worthley SG, Tang C, Zaman AG, Rodriguez OJ, Buchsbaum MS, Fuster V, Badimon JJ. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006; 6:3.
      View in: PubMed
    73. Corti R, Osende J, Hutter R, Viles-Gonzalez JF, Zafar U, Valdivieso C, Mizsei G, Fallon JT, Fuster V, Badimon JJ. Fenofibrate induces plaque regression in hypercholesterolemic atherosclerotic rabbits: in vivo demonstration by high-resolution MRI. Atherosclerosis. 2007 Jan; 190(1):106-13.
      View in: PubMed
    74. Lev EI, Patel R, Karim A, Kleiman A, Badimon JJ, Kleiman NS. Anti-thrombotic effect of bivalirudin compared with eptifibatide and unfractionated heparin in diabetic patients: an ex vivo human study. Thromb Haemost. 2006 Mar; 95(3):441-6.
      View in: PubMed
    75. Wåhlander K, Eriksson-Lepkowska M, Nyström P, Eriksson UG, Sarich TC, Badimon JJ, Kalies I, Elg M, Bylock A. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model. Thromb Haemost. 2006 Mar; 95(3):447-53.
      View in: PubMed
    76. Trocciola SM, Dayal R, Chaer RA, Lin SC, DeRubertis B, Ryer EJ, Hynececk RL, Pierce MJ, Prince M, Badimon J, Marin ML, Fuster V, Kent KC, Faries PL. The development of endotension is associated with increased transmission of pressure and serous components in porous expanded polytetrafluoroethylene stent-grafts: characterization using a canine model. J Vasc Surg. 2006 Jan; 43(1):109-16.
      View in: PubMed
    77. Fuster V, Fayad ZA, Moreno PR, Poon M, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: Part II: approaches by noninvasive computed tomographic/magnetic resonance imaging. J Am Coll Cardiol. 2005 Oct 4; 46(7):1209-18.
      View in: PubMed
    78. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005 Sep 20; 46(6):937-54.
      View in: PubMed
    79. Sirol M, Fuster V, Badimon JJ, Fallon JT, Moreno PR, Toussaint JF, Fayad ZA. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation. 2005 Sep 13; 112(11):1594-600.
      View in: PubMed
    80. Rhee JY, Trocciola SM, Dayal R, Lin S, Chaer R, Kumar N, Mousa A, Bernheim J, Christos P, Prince M, Marin ML, Gordon R, Badimon J, Fuster V, Kent KC, Faries PL. Treatment of type II endoleaks with a novel polyurethane thrombogenic foam: induction of endoleak thrombosis and elimination of intra-aneurysmal pressure in the canine model. J Vasc Surg. 2005 Aug; 42(2):321-8.
      View in: PubMed
    81. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Chaplin WF, Muntwyler J, Viles-Gonzalez JF, Weinberger J, Smith DA, Mizsei G, Badimon JJ. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005 Jul 5; 46(1):106-12.
      View in: PubMed
    82. Shimbo D, Davidson KW, Haas DC, Fuster V, Badimon JJ. Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions. J Thromb Haemost. 2005 May; 3(5):897-908.
      View in: PubMed
    83. Wentzel JJ, Corti R, Fayad ZA, Wisdom P, Macaluso F, Winkelman MO, Fuster V, Badimon JJ. Does shear stress modulate both plaque progression and regression in the thoracic aorta? Human study using serial magnetic resonance imaging. J Am Coll Cardiol. 2005 Mar 15; 45(6):846-54.
      View in: PubMed
    84. Corti R, Badimon J, Mizsei G, Macaluso F, Lee M, Licato P, Viles-Gonzalez JF, Fuster V, Sherman W. Real time magnetic resonance guided endomyocardial local delivery. Heart. 2005 Mar; 91(3):348-53.
      View in: PubMed
    85. Viles-Gonzalez JF, Fuster V, Corti R, Valdiviezo C, Hutter R, Corda S, Anand SX, Badimon JJ. Atherosclerosis regression and TP receptor inhibition: effect of S18886 on plaque size and composition--a magnetic resonance imaging study. Eur Heart J. 2005 Aug; 26(15):1557-61.
      View in: PubMed
    86. Mousa A, Dayal R, Bernheim J, Henderson P, Hollenbeck S, Trocciola S, Prince M, Gordon R, Badimon J, Fuster V, Marin ML, Kent KC, Faries PL. A canine model to study the significance and hemodynamics of type II endoleaks. J Surg Res. 2005 Feb; 123(2):275-83.
      View in: PubMed
    87. Viles-Gonzalez JF, Fuster V, Badimon JJ. Thrombin/inflammation paradigms: a closer look at arterial and venous thrombosis. Am Heart J. 2005 Jan; 149(1 Suppl):S19-31.
      View in: PubMed
    88. Viles-Gonzalez JF, Choi BG, Fuster V, Badimon JJ. Peroxisome proliferator-activated receptor ligands in atherosclerosis. Expert Opin Investig Drugs. 2004 Nov; 13(11):1393-403.
      View in: PubMed
    89. Dayal R, Mousa A, Bernheim J, Hollenbeck S, Henderson P, Prince M, Gordon R, Badimon J, Fuster V, Marin ML, Kent KC, Faries PL. Characterization of retrograde collateral (type II) endoleak using a new canine model. J Vasc Surg. 2004 Nov; 40(5):985-94.
      View in: PubMed
    90. Hutter R, Carrick FE, Valdiviezo C, Wolinsky C, Rudge JS, Wiegand SJ, Fuster V, Badimon JJ, Sauter BV. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury. Circulation. 2004 Oct 19; 110(16):2430-5.
      View in: PubMed
    91. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, Badimon JJ, O'Connor WN. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation. 2004 Oct 5; 110(14):2032-8.
      View in: PubMed
    92. Viles-Gonzalez JF, Poon M, Sanz J, Rius T, Nikolaou K, Fayad ZA, Fuster V, Badimon JJ. In vivo 16-slice, multidetector-row computed tomography for the assessment of experimental atherosclerosis: comparison with magnetic resonance imaging and histopathology. Circulation. 2004 Sep 14; 110(11):1467-72.
      View in: PubMed
    93. Wyttenbach R, Gallino A, Alerci M, Mahler F, Cozzi L, Di Valentino M, Badimon JJ, Fuster V, Corti R. Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopliteal artery by noninvasive magnetic resonance imaging. Circulation. 2004 Aug 31; 110(9):1156-61.
      View in: PubMed
    94. Viles-Gonzalez JF, Fuster V, Badimon JJ. Atherothrombosis: a widespread disease with unpredictable and life-threatening consequences. Eur Heart J. 2004 Jul; 25(14):1197-207.
      View in: PubMed
    95. Viles-Gonzalez JF, Anand SX, Zafar MU, Fuster V, Badimon JJ. Tissue factor coagulation pathway: a new therapeutic target in atherothrombosis. J Cardiovasc Pharmacol. 2004 May; 43(5):669-76.
      View in: PubMed
    96. Viles-Gonzalez JF, Anand SX, Valdiviezo C, Zafar MU, Hutter R, Sanz J, Rius T, Poon M, Fuster V, Badimon JJ. Update in atherothrombotic disease. Mt Sinai J Med. 2004 May; 71(3):197-208.
      View in: PubMed
    97. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, Carrick FE, Bauriedel G, Lüderitz B, Fallon JT, Fuster V, Badimon JJ. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation. 2004 Apr 27; 109(16):2001-8.
      View in: PubMed
    98. Lev EI, Hasdai D, Scapa E, Tobar A, Assali A, Lahav J, Battler A, Badimon JJ, Kornowski R. Administration of eptifibatide to acute coronary syndrome patients receiving enoxaparin or unfractionated heparin: effect on platelet function and thrombus formation. J Am Coll Cardiol. 2004 Mar 17; 43(6):966-71.
      View in: PubMed
    99. Osende JI, Shimbo D, Fuster V, Dubar M, Badimon JJ. Antithrombotic effects of S 18886, a novel orally active thromboxane A2 receptor antagonist. J Thromb Haemost. 2004 Mar; 2(3):492-8.
      View in: PubMed
    100. Corti R, Osende JI, Fallon JT, Fuster V, Mizsei G, Jneid H, Wright SD, Chaplin WF, Badimon JJ. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2004 Feb 4; 43(3):464-73.
      View in: PubMed
    101. Corti R, Hutter R, Badimon JJ, Fuster V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J Thromb Thrombolysis. 2004 Feb; 17(1):35-44.
      View in: PubMed
    102. Spieker LE, Ruschitzka F, Badimon JJ, Noll G, Corti R. Shear stress-dependent platelet function after LDL cholesterol apheresis. Thromb Res. 2004; 113(6):395-8.
      View in: PubMed
    103. Viles-Gonzalez JF, Badimon JJ. Atherothrombosis: the role of tissue factor. Int J Biochem Cell Biol. 2004 Jan; 36(1):25-30.
      View in: PubMed
    104. Viles-Gonzalez JF, Gaztanaga J, Zafar UM, Fuster V, Badimon JJ. Clinical and experimental experience with factor Xa inhibitors. Am J Cardiovasc Drugs. 2004; 4(6):379-84.
      View in: PubMed
    105. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation. 2003 Oct 14; 108(15):1772-8.
      View in: PubMed
    106. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003 Oct 7; 108(14):1664-72.
      View in: PubMed
    107. Bauriedel G, Jabs A, Skowasch D, Hutter R, Badimon JJ, Fuster V, Welsch U, Lüderitz B. Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol. 2003 Sep 3; 42(5):930-8.
      View in: PubMed
    108. Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD. Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost. 2003 Sep; 90(3):377-84.
      View in: PubMed
    109. Fuster V, Corti R, Fayad ZA, Schwitter J, Badimon JJ. Integration of vascular biology and magnetic resonance imaging in the understanding of atherothrombosis and acute coronary syndromes. J Thromb Haemost. 2003 Jul; 1(7):1410-21.
      View in: PubMed
    110. Viles-Gonzalez JF, Fuster V, Corti R, Badimon JJ. Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes. Curr Opin Cardiol. 2003 Jul; 18(4):286-94.
      View in: PubMed
    111. Gomberg-Maitland M, Fuster V, Fayad ZA, Badimon JJ, Corti R. Statins and plaque stability. J Cardiovasc Risk. 2003 Jun; 10(3):161-7.
      View in: PubMed
    112. Jneid H, Bhatt DL, Corti R, Badimon JJ, Fuster V, Francis GS. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study. Arch Intern Med. 2003 May 26; 163(10):1145-53.
      View in: PubMed
    113. Sarich TC, Osende JI, Eriksson UG, Fager GB, Eriksson-Lepkowska M, Ohlsson L, Carlsson S, Wåhlander K, Gustafsson D, Badimon JJ. Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosis. J Thromb Haemost. 2003 May; 1(5):999-1004.
      View in: PubMed
    114. Hutter R, Sauter BV, Reis ED, Roque M, Vorchheimer D, Carrick FE, Fallon JT, Fuster V, Badimon JJ. Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury. Circulation. 2003 Apr 1; 107(12):1658-63.
      View in: PubMed
    115. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003 Feb 25; 107(7):973-7.
      View in: PubMed
    116. Rastegar R, Harnick DJ, Weidemann P, Fuster V, Coller B, Badimon JJ, Chesebro J, Goldman ME. Spontaneous echo contrast videodensity is flow-related and is dependent on the relative concentrations of fibrinogen and red blood cells. J Am Coll Cardiol. 2003 Feb 19; 41(4):603-10.
      View in: PubMed
    117. Corti R, Fuster V, Badimon JJ. Pathogenetic concepts of acute coronary syndromes. J Am Coll Cardiol. 2003 Feb 19; 41(4 Suppl S):7S-14S.
      View in: PubMed
    118. Worthley SG, Helft G, Fuster V, Fayad ZA, Shinnar M, Minkoff LA, Schechter C, Fallon JT, Badimon JJ. A novel nonobstructive intravascular MRI coil: in vivo imaging of experimental atherosclerosis. Arterioscler Thromb Vasc Biol. 2003 Feb 1; 23(2):346-50.
      View in: PubMed
    119. Corti R, Fuster V, Fayad ZA, Worthley SG, Helft G, Smith D, Weinberger J, Wentzel J, Mizsei G, Mercuri M, Badimon JJ. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation. 2002 Dec 3; 106(23):2884-7.
      View in: PubMed
    120. Corti R, Farkouh ME, Badimon JJ. The vulnerable plaque and acute coronary syndromes. Am J Med. 2002 Dec 1; 113(8):668-80.
      View in: PubMed
    121. Shimbo D, Osende J, Chen J, Robbins J, Shimoto Y, Kunitada S, Fuster V, Badimon JJ. Antithrombotic effects of DX-9065a, a direct factor Xa inhibitor: a comparative study in humans versus low molecular weight heparin. Thromb Haemost. 2002 Nov; 88(5):733-8.
      View in: PubMed
    122. Badimon JJ, Fuster V. Can we image the "active" thrombus? Arterioscler Thromb Vasc Biol. 2002 Nov 1; 22(11):1753-4.
      View in: PubMed
    123. Corti R, Badimon JJ. Biologic aspects of vulnerable plaque. Curr Opin Cardiol. 2002 Nov; 17(6):616-25.
      View in: PubMed
    124. Corti R, Wyttenbach R, Alerci M, Badimon JJ, Fuster V, Gallino A. Images in cardiovascular medicine. Effect of percutaneous transluminal angioplasty on severely stenotic femoral lesions: in vivo demonstration by noninvasive magnetic resonance imaging. Circulation. 2002 Sep 17; 106(12):1570-1.
      View in: PubMed
    125. Fuster V, Corti R, Badimon JJ. The Mikamo Lecture 2002. Therapeutic targets for the treatment of atherothrombosis in the new millennium--clinical frontiers in atherosclerosis research. Circ J. 2002 Sep; 66(9):783-90.
      View in: PubMed
    126. Badimon L, Badimon JJ, Vilahur G, Segalés E, Llorente V. Pathogenesis of the acute coronary syndromes and therapeutic implications. Pathophysiol Haemost Thromb. 2002 Sep-Dec; 32(5-6):225-31.
      View in: PubMed
    127. Choudhury RP, Fuster V, Badimon JJ, Fisher EA, Fayad ZA. MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging. Arterioscler Thromb Vasc Biol. 2002 Jul 1; 22(7):1065-74.
      View in: PubMed
    128. Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ. Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study. Arterioscler Thromb Vasc Biol. 2002 Jun 1; 22(6):1036-41.
      View in: PubMed
    129. Borreguero LJ, Corti R, de Soria RF, Osende JI, Fuster V, Badimon JJ. Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging. Circulation. 2002 May 28; 105(21):E177-8.
      View in: PubMed
    130. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002 Apr 17; 39(8):1366-73.
      View in: PubMed
    131. Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimon JJ, Charo IF, Taubman MB. CCR2 deficiency decreases intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol. 2002 Apr 1; 22(4):554-9.
      View in: PubMed
    132. Silva EP, Fonseca FA, Ihara SS, Izar MC, Lopes IL, Pinto LE, Badimon JJ, Tuffik S, Paiva TB, Kasinski N, de Paola AV, Carvalho AC. Early benefits of pravastatin to experimentally induced atherosclerosis. J Cardiovasc Pharmacol. 2002 Mar; 39(3):389-95.
      View in: PubMed
    133. Helft G, Worthley SG, Fuster V, Fayad ZA, Zaman AG, Corti R, Fallon JT, Badimon JJ. Progression and regression of atherosclerotic lesions: monitoring with serial noninvasive magnetic resonance imaging. Circulation. 2002 Feb 26; 105(8):993-8.
      View in: PubMed
    134. Poon M, Badimon JJ, Fuster V. Overcoming restenosis with sirolimus: from alphabet soup to clinical reality. Lancet. 2002 Feb 16; 359(9306):619-22.
      View in: PubMed
    135. Shimbo D, Child J, Davidson K, Geer E, Osende JI, Reddy S, Dronge A, Fuster V, Badimon JJ. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol. 2002 Feb 1; 89(3):331-3.
      View in: PubMed
    136. Corti R, Fuster V, Badimon JJ, Hutter R, Fayad ZA. New understanding of atherosclerosis (clinically and experimentally) with evolving MRI technology in vivo. Ann N Y Acad Sci. 2001 Dec; 947:181-95; discussion 195-8.
      View in: PubMed
    137. Corti R, Badimon JJ. Value or desirability of hemorheological-hemostatic parameter changes as endpoints in blood lipid-regulating trials. Curr Opin Lipidol. 2001 Dec; 12(6):629-37.
      View in: PubMed
    138. Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhun R, Zaman A, Rodriguez OJ, Lev EI, Rauch U, Heflt G, Fallon JT, Crandall JP. Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control. J Am Coll Cardiol. 2001 Nov 1; 38(5):1307-12.
      View in: PubMed
    139. Kerr AS, Osende J, Fallon JT, Badimon J. Aortic Slimgraft: ex vivo and in vivo study. J Vasc Surg. 2001 Aug; 34(2):350-2.
      View in: PubMed
    140. Corti R, Fayad ZA, Fuster V, Worthley SG, Helft G, Chesebro J, Mercuri M, Badimon JJ. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation. 2001 Jul 17; 104(3):249-52.
      View in: PubMed
    141. Worthley SG, Helft G, Fayad ZA, Fuster V, Rodriguez OJ, Zaman AG, Badimon JJ. Cardiac gated breath-hold black blood MRI of the coronary artery wall: an in vivo and ex vivo comparison. Int J Cardiovasc Imaging. 2001 Jun; 17(3):195-201.
      View in: PubMed
    142. Roqué M, Reis ED, Cordon-Cardo C, Taubman MB, Fallon JT, Fuster V, Badimon JJ. Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model. Lab Invest. 2001 Jun; 81(6):895-903.
      View in: PubMed
    143. Helft G, Worthley SG, Beygui F, Zaman AG, Le Feuvre C, Vacheron A, Metzger JP, Badimon JJ, Fuster V. [Identification of unstable coronary atherosclerotic plaques]. Arch Mal Coeur Vaiss. 2001 Jun; 94(6):583-90.
      View in: PubMed
    144. Kusunoki J, Hansoty DK, Aragane K, Fallon JT, Badimon JJ, Fisher EA. Acyl-CoA:cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001 May 29; 103(21):2604-9.
      View in: PubMed
    145. Corti R, Osende JI, Fuster V, Fayad ZA, Fallon JT, Badimon JJ. Artery dissection and arterial thrombus aging: the role of noninvasive magnetic resonance imaging. Circulation. 2001 May 15; 103(19):2420-1.
      View in: PubMed
    146. Worthley SG, Osende JI, Helft G, Badimon JJ, Fuster V. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med. 2001 May; 68(3):167-81.
      View in: PubMed
    147. Osende JI, Fuster V, Lev EI, Shimbo D, Rauch U, Marmur JD, Richard M, Varon D, Badimon JJ. Testing platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition. Circulation. 2001 Mar 20; 103(11):1488-91.
      View in: PubMed
    148. Helft G, Worthley SG, Fuster V, Zaman AG, Schechter C, Osende JI, Rodriguez OJ, Fayad ZA, Fallon JT, Badimon JJ. Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. J Am Coll Cardiol. 2001 Mar 15; 37(4):1149-54.
      View in: PubMed
    149. Lev EI, Osende JI, Richard MF, Robbins JA, Delfin JA, Rodriguez O, Sharma SK, Jayasundera T, Badimon JJ, Marmur JD. Administration of abciximab to patients receiving tirofiban or eptifibatide: effect on platelet function. J Am Coll Cardiol. 2001 Mar 1; 37(3):847-55.
      View in: PubMed
    150. Rauch U, Osende JI, Fuster V, Badimon JJ, Fayad Z, Chesebro JH. Thrombus formation on atherosclerotic plaques: pathogenesis and clinical consequences. Ann Intern Med. 2001 Feb 6; 134(3):224-38.
      View in: PubMed
    151. Fonseca FA, Izar MC, Fuster V, Gallo R, Padurean A, Fallon JT, Schachter EN, Chesebro JH, Badimon JJ. Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro. Atherosclerosis. 2001 Jan; 154(1):61-9.
      View in: PubMed
    152. Worthley SG, Helft G, Zaman AG, Fuster V, Badimon JJ. Atherosclerosis and the vulnerable plaque--imaging: Part II. Aust N Z J Med. 2000 Dec; 30(6):704-10.
      View in: PubMed
    153. Roque M, Cordon-Cardo C, Fuster V, Reis ED, Drobnjak M, Badimon JJ. Modulation of apoptosis, proliferation, and p27 expression in a porcine coronary angioplasty model. Atherosclerosis. 2000 Dec; 153(2):315-22.
      View in: PubMed
    154. Roqué M, Reis ED, Fuster V, Padurean A, Fallon JT, Taubman MB, Chesebro JH, Badimon JJ. Inhibition of tissue factor reduces thrombus formation and intimal hyperplasia after porcine coronary angioplasty. J Am Coll Cardiol. 2000 Dec; 36(7):2303-10.
      View in: PubMed
    155. Reis ED, Roque M, Dansky H, Fallon JT, Badimon JJ, Cordon-Cardo C, Shiff SJ, Fisher EA. Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2000 Nov 7; 97(23):12764-9.
      View in: PubMed
    156. Reis ED, Roqué M, Cordon-Cardo C, Drobnjak M, Fuster V, Badimon JJ. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vasc Surg. 2000 Nov; 32(5):1022-9.
      View in: PubMed
    157. Rauch U, Osende JI, Chesebro JH, Fuster V, Vorchheimer DA, Harris K, Harris P, Sandler DA, Fallon JT, Jayaraman S, Badimon JJ. Statins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 2000 Nov; 153(1):181-9.
      View in: PubMed
    158. Helft G, Osende JI, Worthley SG, Zaman AG, Rodriguez OJ, Lev EI, Farkouh ME, Fuster V, Badimon JJ, Chesebro JH. Acute antithrombotic effect of a front-loaded regimen of clopidogrel in patients with atherosclerosis on aspirin. Arterioscler Thromb Vasc Biol. 2000 Oct; 20(10):2316-21.
      View in: PubMed
    159. Worthley SG, Helft G, Zaman AG, Fuster V, Badimon JJ. Atherosclerosis and the vulnerable plaque--pathogenesis: Part I. Aust N Z J Med. 2000 Oct; 30(5):600-7.
      View in: PubMed
    160. Fayad ZA, Fuster V, Fallon JT, Jayasundera T, Worthley SG, Helft G, Aguinaldo JG, Badimon JJ, Sharma SK. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000 Aug 1; 102(5):506-10.
      View in: PubMed
    161. Rauch U, Crandall J, Osende JI, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2. Am J Cardiol. 2000 Jul 15; 86(2):246-9.
      View in: PubMed
    162. Ambrose JA, Hawkey M, Badimon JJ, Coppola J, Geagea J, Rentrop KP, Domiguez A, Duvvuri S, Elmquist T, Arias J, Doss R, Dangas G. In vivo demonstration of an antithrombin effect of abciximab. Am J Cardiol. 2000 Jul 15; 86(2):150-2.
      View in: PubMed
    163. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000 Jul 1; 96(1):170-5.
      View in: PubMed
    164. Helft G, Worthley SG, Zaman AG, Samama MM, Badimon JJ. Thrombolysis and adjunctive therapies in acute myocardial infarction. Haemostasis. 2000 Jul-Aug; 30(4):159-67.
      View in: PubMed
    165. Worthley SG, Helft G, Fuster V, Fayad ZA, Rodriguez OJ, Zaman AG, Fallon JT, Badimon JJ. Noninvasive in vivo magnetic resonance imaging of experimental coronary artery lesions in a porcine model. Circulation. 2000 Jun 27; 101(25):2956-61.
      View in: PubMed
    166. Roqué M, Rauch U, Reis ED, Chesebro JH, Fuster V, Badimon JJ. Comparative study of antithrombotic effect of a low molecular weight heparin and unfractionated heparin in an ex vivo model of deep arterial injury. Thromb Res. 2000 Jun 15; 98(6):499-505.
      View in: PubMed
    167. Worthley SG, Helft G, Fayad ZA, Fuster V, Zaman AG, Shinnar M, Badimon JJ. Images in cardiovascular medicine. Magnetic resonance imaging and asymptomatic aortic dissection. Circulation. 2000 Jun 13; 101(23):2771.
      View in: PubMed
    168. Worthley SG, Helft G, Fuster V, Fayad ZA, Fallon JT, Osende JI, Roqué M, Shinnar M, Zaman AG, Rodriguez OJ, Verhallen P, Badimon JJ. High resolution ex vivo magnetic resonance imaging of in situ coronary and aortic atherosclerotic plaque in a porcine model. Atherosclerosis. 2000 Jun; 150(2):321-9.
      View in: PubMed
    169. Fayad ZA, Nahar T, Fallon JT, Goldman M, Aguinaldo JG, Badimon JJ, Shinnar M, Chesebro JH, Fuster V. In vivo magnetic resonance evaluation of atherosclerotic plaques in the human thoracic aorta: a comparison with transesophageal echocardiography. Circulation. 2000 May 30; 101(21):2503-9.
      View in: PubMed
    170. Hayes R, Chesebro JH, Fuster V, Dangas G, Fallon JT, Sharma SK, Coller BS, Badimon L, Marmur JD, Badimon JJ. Antithrombotic effects of abciximab. Am J Cardiol. 2000 May 15; 85(10):1167-72.
      View in: PubMed
    171. Dangas G, Smith DA, Unger AH, Shao JH, Meraj P, Fier C, Cohen AM, Fallon JT, Badimon JJ, Ambrose JA. Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect. Thromb Haemost. 2000 May; 83(5):688-92.
      View in: PubMed
    172. Giesen PL, Fyfe BS, Fallon JT, Roque M, Mendlowitz M, Rossikhina M, Guha A, Badimon JJ, Nemerson Y, Taubman MB. Intimal tissue factor activity is released from the arterial wall after injury. Thromb Haemost. 2000 Apr; 83(4):622-8.
      View in: PubMed
    173. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 2000 Apr; 149(2):251-66.
      View in: PubMed
    174. Zaman AG, Osende JI, Chesebro JH, Fuster V, Padurean A, Gallo R, Worthley SG, Helft G, Rodriguez OX, Fallon JT, Badimon JJ. In vivo dynamic real-time monitoring and quantification of platelet-thrombus formation: use of a local isotope detector. Arterioscler Thromb Vasc Biol. 2000 Mar; 20(3):860-5.
      View in: PubMed
    175. Worthley SG, Helft G, Fuster V, Zaman AG, Fayad ZA, Fallon JT, Badimon JJ. Serial in vivo MRI documents arterial remodeling in experimental atherosclerosis. Circulation. 2000 Feb 15; 101(6):586-9.
      View in: PubMed
    176. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED. Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000 Feb; 20(2):335-42.
      View in: PubMed
    177. Badimon L, Martínez-González J, Royo T, Lassila R, Badimon JJ. A sudden increase in plasma epinephrine levels transiently enhances platelet deposition on severely damaged arterial wall--studies in a porcine model. Thromb Haemost. 1999 Dec; 82(6):1736-42.
      View in: PubMed
    178. Freudenberger R, Alexis J, Gass A, Fuster V, Badimon J. Antithrombotic effect of FK506 vs cyclosporine in cardiac transplant recipients: potential implications in transplant arteriopathy. J Heart Lung Transplant. 1999 Dec; 18(12):1228-31.
      View in: PubMed
    179. Shinnar M, Fallon JT, Wehrli S, Levin M, Dalmacy D, Fayad ZA, Badimon JJ, Harrington M, Harrington E, Fuster V. The diagnostic accuracy of ex vivo MRI for human atherosclerotic plaque characterization. Arterioscler Thromb Vasc Biol. 1999 Nov; 19(11):2756-61.
      View in: PubMed
    180. Dangas G, Smith DA, Badimon JJ, Unger AH, Shao JH, Meraj P, Cohen AM, Levine D, Fallon JT, Ambrose JA. Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin. Am J Cardiol. 1999 Sep 15; 84(6):639-43.
      View in: PubMed
    181. Gallo R, Chesebro JH, Badimon JJ. Treatment of unstable angina: role of antithrombotic therapy. Thromb Res. 1999 Aug 1; 95(3):V15-31.
      View in: PubMed
    182. Badimon JJ, Zaman A, Helft G, Fayad Z, Fuster V. Acute coronary syndromes: pathophysiology and preventive priorities. Thromb Haemost. 1999 Aug; 82(2):997-1004.
      View in: PubMed
    183. Roque M, Badimon L, Badimon JJ. Pathophysiology of unstable angina. Thromb Res. 1999 Aug 1; 95(3):V5-14.
      View in: PubMed
    184. Zaman AG, Helft G, Osende JI, Fuster V, Badimon JJ. Histopathology and pathogenesis of plaque instability and thrombus formation. Drugs Today (Barc). 1999 Aug; 35(8):641-56.
      View in: PubMed
    185. Dangas G, Marmur JD, King TE, De Leon J, Sharma SK, Vidhun R, Feldman D, Stoynov MY, Badimon JJ, Ambrose JA. Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention. Am Heart J. 1999 Jul; 138(1 Pt 1):49-54.
      View in: PubMed
    186. Fuster V, Fayad ZA, Badimon JJ. Acute coronary syndromes: biology. Lancet. 1999 Jun; 353 Suppl 2:SII5-9.
      View in: PubMed
    187. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation. 1999 Apr 27; 99(16):2164-70.
      View in: PubMed
    188. Vorchheimer DA, Badimon JJ, Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA. 1999 Apr 21; 281(15):1407-14.
      View in: PubMed
    189. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation. 1999 Apr 13; 99(14):1780-7.
      View in: PubMed
    190. Dangas G, Badimon JJ, Smith DA, Unger AH, Levine D, Shao JH, Meraj P, Fier C, Fallon JT, Ambrose JA. Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile. J Am Coll Cardiol. 1999 Apr; 33(5):1294-304.
      View in: PubMed
    191. Giesen PL, Rauch U, Bohrmann B, Kling D, Roqué M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999 Mar 2; 96(5):2311-5.
      View in: PubMed
    192. Fayad ZA, Fallon JT, Shinnar M, Wehrli S, Dansky HM, Poon M, Badimon JJ, Charlton SA, Fisher EA, Breslow JL, Fuster V. Noninvasive In vivo high-resolution magnetic resonance imaging of atherosclerotic lesions in genetically engineered mice. Circulation. 1998 Oct 13; 98(15):1541-7.
      View in: PubMed
    193. Badimon JJ, Ortiz AF, Meyer B, Mailhac A, Fallon JT, Falk E, Badimon L, Chesebro JH, Fuster V. Different response to balloon angioplasty of carotid and coronary arteries: effects on acute platelet deposition and intimal thickening. Atherosclerosis. 1998 Oct; 140(2):307-14.
      View in: PubMed
    194. Gertz SD, Fallon JT, Gallo R, Taubman MB, Banai S, Barry WL, Gimple LW, Nemerson Y, Thiruvikraman S, Naidu SS, Chesebro JH, Fuster V, Sarembock IJ, Badimon JJ. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries. Circulation. 1998 Aug 11; 98(6):580-7.
      View in: PubMed
    195. Dangas G, Badimon JJ, Coller BS, Fallon JT, Sharma SK, Hayes RM, Meraj P, Ambrose JA, Marmur JD. Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab. Arterioscler Thromb Vasc Biol. 1998 Aug; 18(8):1342-9.
      View in: PubMed
    196. Chesebro JH, Badimon JJ. Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease. N Engl J Med. 1998 May 21; 338(21):1539-41.
      View in: PubMed
    197. Meyer BJ, Badimon JJ, Chesebro JH, Fallon JT, Fuster V, Badimon L. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. Circulation. 1998 Feb 24; 97(7):681-5.
      View in: PubMed
    198. Gallo R, Padurean A, Toschi V, Bichler J, Fallon JT, Chesebro JH, Fuster V, Badimon JJ. Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries. Circulation. 1998 Feb 17; 97(6):581-8.
      View in: PubMed
    199. Gallo R, Badimon JJ, Fuster V. Pathobiology of coronary ischemic events: clinical implications. Adv Intern Med. 1998; 43:203-32.
      View in: PubMed
    200. Fuster V, Badimon JJ, Chesebro JH. Atherothrombosis: mechanisms and clinical therapeutic approaches. Vasc Med. 1998; 3(3):231-9.
      View in: PubMed
    201. Viñals M, Martínez-González J, Badimon JJ, Badimon L. HDL-induced prostacyclin release in smooth muscle cells is dependent on cyclooxygenase-2 (Cox-2). Arterioscler Thromb Vasc Biol. 1997 Dec; 17(12):3481-8.
      View in: PubMed
    202. Fuster V, Fallon JT, Badimon JJ, Nemerson Y. The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost. 1997 Jul; 78(1):247-55.
      View in: PubMed
    203. Badimon JJ, Meyer B, Feigen LP, Baron DA, Chesebro JH, Fuster V, Badimon L. Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist. Eur J Clin Invest. 1997 Jul; 27(7):568-74.
      View in: PubMed
    204. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernández-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 1997 Feb 4; 95(3):594-9.
      View in: PubMed
    205. Chesebro JH, Rauch U, Fuster V, Badimon JJ. Pathogenesis of thrombosis in coronary artery disease. Haemostasis. 1997; 27 Suppl 1:12-8.
      View in: PubMed
    206. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest. 1996 Nov 15; 98(10):2277-83.
      View in: PubMed
    207. Fuster V, Badimon J, Chesebro JH, Fallon JT. Plaque rupture, thrombosis, and therapeutic implications. Haemostasis. 1996 Oct; 26 Suppl 4:269-84.
      View in: PubMed
    208. Toschi V, Lettino M, Gallo R, Badimon JJ, Chesebro JH. Biochemistry and biology of hirudin. Coron Artery Dis. 1996 Jun; 7(6):420-8.
      View in: PubMed
    209. Lettino M, Dailey-Sterling F, Badimon L, Chesebro JH, Badimon JJ. Wall passivation for unstable angina. Semin Interv Cardiol. 1996 Mar; 1(1):60-6.
      View in: PubMed
    210. Pueyo C, Badimon JJ, Royo T, Feigen LP, Badimon L. A mimetic of the RGDF-peptide [arginine-glycine-aspartic acid-phenylalanine] blocks aggregation and flow-induced platelet deposition on severely injured stenotic arterial wall. Effects on different animal models and in humans. Thromb Res. 1996 Jan 1; 81(1):101-12.
      View in: PubMed
    211. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995 Sep 15; 92(6):1565-9.
      View in: PubMed
    212. Chesebro JH, Toschi V, Lettino M, Gallo R, Badimon JJ, Fallon JT, Fuster V. Evolving concepts in the pathogenesis and treatment of arterial thrombosis. Mt Sinai J Med. 1995 Sep; 62(4):275-86.
      View in: PubMed
    213. Fernandez-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon JJ. Potential applications of iontophoresis for local drug delivery of vascular diseases. J Interv Cardiol. 1995 Aug; 8(4):420-6.
      View in: PubMed
    214. Fuster V, Badimon JJ. Regression or stabilization of atherosclerosis means regression or stabilization of what we don't see in the arteriogram. Eur Heart J. 1995 Jul; 16 Suppl E:6-12.
      View in: PubMed
    215. Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost. 1995 Jul; 74(1):552-9.
      View in: PubMed
    216. Badimon L, Royo T, Martínez-González J, Badimon JJ. [Development of coronary arteriosclerosis and its clinical complications]. Med Clin (Barc). 1995 Jan 28; 104(3):105-14.
      View in: PubMed
    217. Badimon L, Alfon J, Royo T, Berrozpe M, Martinez-Gonzalez J, Vidal F, Chesebro JH, Fuster V, Badimon JJ. Cell biology of restenosis post-angioplasty. Z Kardiol. 1995; 84 Suppl 4:145-9.
      View in: PubMed
    218. Meyer BJ, Badimon JJ, Mailhac A, Fernández-Ortiz A, Chesebro JH, Fuster V, Badimon L. Inhibition of growth of thrombus on fresh mural thrombus. Targeting optimal therapy. Circulation. 1994 Nov; 90(5):2432-8.
      View in: PubMed
    219. Meyer BJ, Fernández-Ortiz A, Mailhac A, Falk E, Badimon L, Michael AD, Chesebro JH, Fuster V, Badimon JJ. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation. 1994 Nov; 90(5):2474-80.
      View in: PubMed
    220. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Synergistic action of severe wall injury and shear forces on thrombus formation in arterial stenosis: definition of a thrombotic shear rate threshold. J Am Coll Cardiol. 1994 Oct; 24(4):1091-7.
      View in: PubMed
    221. Pfliegler G, el-Gamal B, Badimon JJ, Badimon L, Crawford N. Inhibition of platelet recruitment to arterial lesions by predeposition of platelets containing encapsulated iloprost. Thromb Haemost. 1994 Oct; 72(4):604-10.
      View in: PubMed
    222. Apitz-Castro R, Badimon JJ, Badimon L. A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model. Thromb Res. 1994 Aug 1; 75(3):243-9.
      View in: PubMed
    223. Mailhac A, Badimon JJ, Fallon JT, Fernández-Ortiz A, Meyer B, Chesebro JH, Fuster V, Badimon L. Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. Circulation. 1994 Aug; 90(2):988-96.
      View in: PubMed
    224. Fernández-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994 Jun; 23(7):1562-9.
      View in: PubMed
    225. Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity. Thromb Haemost. 1994 Apr; 71(4):511-6.
      View in: PubMed
    226. Fernández-Ortiz A, Meyer BJ, Mailhac A, Falk E, Badimon L, Fallon JT, Fuster V, Chesebro JH, Badimon JJ. A new approach for local intravascular drug delivery. Iontophoretic balloon. Circulation. 1994 Apr; 89(4):1518-22.
      View in: PubMed
    227. Badimon L, Royo T, Badimon JJ, Chesebro JH, Fuster V. Intrinsic thrombus modifications favouring embolization. G Ital Cardiol. 1994 Mar; 24(3):215-24.
      View in: PubMed
    228. Badimon L, Meyer BJ, Badimon JJ. Thrombin in arterial thrombosis. Haemostasis. 1994 Mar-Apr; 24(2):69-80.
      View in: PubMed
    229. Alexopoulos D, Sanborn TA, Marmur JD, Badimon JJ, Badimon L, Dische R, Fuster V. Acute biological response to laser balloon angioplasty in the atherosclerotic rabbit. Lasers Surg Med. 1994; 14(1):7-12.
      View in: PubMed
    230. Chesebro JH, Badimon JJ, Ortiz AF, Meyer BJ, Fuster V. Conjunctive antithrombotic therapy for thrombolysis in myocardial infarction. Am J Cardiol. 1993 Dec 16; 72(19):66G-74G.
      View in: PubMed
    231. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost. 1993 Jul 1; 70(1):111-8.
      View in: PubMed
    232. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis. A multifactorial disease. Circulation. 1993 Mar; 87(3 Suppl):II3-16.
      View in: PubMed
    233. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation. 1992 Dec; 86(6 Suppl):III74-85.
      View in: PubMed
    234. Fuster V, Badimon JJ, Badimon L. Clinical-pathological correlations of coronary disease progression and regression. Circulation. 1992 Dec; 86(6 Suppl):III1-11.
      View in: PubMed
    235. Badimon JJ, Fuster V, Badimon L. Role of high density lipoproteins in the regression of atherosclerosis. Circulation. 1992 Dec; 86(6 Suppl):III86-94.
      View in: PubMed
    236. Merino A, Hauptman P, Badimon L, Badimon JJ, Cohen M, Fuster V, Goldman M. Echocardiographic "smoke" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol. 1992 Dec; 20(7):1661-8.
      View in: PubMed
    237. Chesebro JH, Webster MW, Zoldhelyi P, Roche PC, Badimon L, Badimon JJ. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins. Circulation. 1992 Dec; 86(6 Suppl):III100-10.
      View in: PubMed
    238. Pearlman JD, Badimon JJ. Atherosclerotic plaque detection by nuclear magnetic resonance and radiolabeled autologous low-density lipoprotein. Am J Card Imaging. 1992 Dec; 6(4):325-32.
      View in: PubMed
    239. Apitz-Castro R, Badimon JJ, Badimon L. Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation. Thromb Res. 1992 Oct 15; 68(2):145-55.
      View in: PubMed
    240. Lam JY, Badimon JJ, Ellefson RD, Fuster V, Chesebro JH. Cod liver oil alters platelet-arterial wall response to injury in pigs. Circ Res. 1992 Oct; 71(4):769-75.
      View in: PubMed
    241. Badimon L, Badimon JJ, Penny W, Webster MW, Chesebro JH, Fuster V. Endothelium and atherosclerosis. J Hypertens Suppl. 1992 Apr; 10(2):S43-50.
      View in: PubMed
    242. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med. 1992 Jan 30; 326(5):310-8.
      View in: PubMed
    243. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med. 1992 Jan 23; 326(4):242-50.
      View in: PubMed
    244. Badimon L, Merino A, Badimon J, Chesebro JH, Fuster V. Hirudin and other thrombin inhibitors experimental results and potential clinical applications. Trends Cardiovasc Med. 1991 Sep; 1(6):261-7.
      View in: PubMed
    245. Fuster V, Badimon L, Badimon JJ, Ip JH, Chesebro JH. The porcine model for the understanding of thrombogenesis and atherogenesis. Mayo Clin Proc. 1991 Aug; 66(8):818-31.
      View in: PubMed
    246. Badimon L, Badimon JJ, Lassila R, Heras M, Chesebro JH, Fuster V. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation. Blood. 1991 Jul 15; 78(2):423-34.
      View in: PubMed
    247. Fuster V, Ip JH, Badimon L, Badimon JJ, Stein B, Chesebro JH. Importance of experimental models for the development of clinical trials on thromboatherosclerosis. Circulation. 1991 Jun; 83(6 Suppl):IV15-25.
      View in: PubMed
    248. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 1991 May; 17(6 Suppl B):77B-88B.
      View in: PubMed
    249. Marmur JD, Sanborn TA, Kahn H, Badimon JJ, Badimon L, Fuster V. Acute biologic response to excimer versus thermal laser angioplasty in experimental atherosclerosis. J Am Coll Cardiol. 1991 Mar 15; 17(4):978-84.
      View in: PubMed
    250. Badimon JJ, Badimon L, Turitto VT, Fuster V. Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model. Arterioscler Thromb. 1991 Mar-Apr; 11(2):395-402.
      View in: PubMed
    251. Badimon L, Badimon JJ, Cohen M, Chesebro JH, Fuster V. Vessel wall-related risk factors in acute vascular events. Drugs. 1991; 42 Suppl 5:1-9.
      View in: PubMed
    252. Alexopoulos D, Sanborn TA, Badimon JJ, Badimon L, Dische R, Fuster V. Coronary laser thermal angioplasty in the swine: reduced complications with shorter laser delivery time. J Interv Cardiol. 1991; 4(3):189-97.
      View in: PubMed
    253. Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic plaque rupture and thrombosis. Evolving concepts. Circulation. 1990 Sep; 82(3 Suppl):II47-59.
      View in: PubMed
    254. Sanborn TA, Alexopoulos D, Marmur JD, Kahn H, Badimon JJ, Badimon L, Fuster V. Coronary excimer laser angioplasty: reduced complications and indium-111 platelet accumulation compared with thermal laser angioplasty. J Am Coll Cardiol. 1990 Aug; 16(2):502-6.
      View in: PubMed
    255. Badimon L, Badimon JJ, Turitto VT, Fuster V. Platelet interaction to prosthetic materials--role of von Willebrand factor in platelet interaction to PTFE. J Biomater Appl. 1990 Jul; 5(1):27-48.
      View in: PubMed
    256. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990 Jun; 15(7):1667-87.
      View in: PubMed
    257. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990 Apr; 85(4):1234-41.
      View in: PubMed
    258. Lassila R, Badimon JJ, Vallabhajosula S, Badimon L. Dynamic monitoring of platelet deposition on severely damaged vessel wall in flowing blood. Effects of different stenoses on thrombus growth. Arteriosclerosis. 1990 Mar-Apr; 10(2):306-15.
      View in: PubMed
    259. Badimon L, Badimon JJ, Fuster V. Thrombogenesis and inhibition of platelet aggregation. Experimental aspects and future approaches. Z Kardiol. 1990; 79 Suppl 3:133-45.
      View in: PubMed
    260. Badimon L, Badimon JJ. Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. J Clin Invest. 1989 Oct; 84(4):1134-44.
      View in: PubMed
    261. Stein B, Fuster V, Israel DH, Cohen M, Badimon L, Badimon JJ, Chesebro JH. Platelet inhibitor agents in cardiovascular disease: an update. J Am Coll Cardiol. 1989 Oct; 14(4):813-36.
      View in: PubMed
    262. Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis. 1989 Mar-Apr; 9(2):159-66.
      View in: PubMed
    263. Badimon L, Badimon JJ, Turitto VT, Rand J, Fuster V. Functional behavior of vessels from pigs with von Willebrand disease. Values of platelet deposition are identical to those obtained on normal vessels. Arteriosclerosis. 1989 Mar-Apr; 9(2):184-8.
      View in: PubMed
    264. Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest. 1989 Mar; 60(3):455-61.
      View in: PubMed
    265. Badimon L, Badimon JJ, Turitto VT, Fuster V. Role of von Willebrand factor in mediating platelet-vessel wall interaction at low shear rate; the importance of perfusion conditions. Blood. 1989 Mar; 73(4):961-7.
      View in: PubMed
    266. Badimon L, Badimon JJ, Galvez A, Turitto V, Fuster V. Platelet interaction with vessel wall and collagen in pigs with homozygous von Willebrand's disease associated with abnormal collagen aggregation. Thromb Haemost. 1989 Feb 28; 61(1):57-64.
      View in: PubMed
    267. Stein B, Badimon L, Israel DH, Badimon JJ, Fuster V. Thrombosis/platelets and other blood factors in acute coronary syndromes. Cardiovasc Clin. 1989; 20(1):105-29.
      View in: PubMed
    268. Badimon L, Badimon JJ, Turitto VT, Vallabhajosula S, Fuster V. Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation. Circulation. 1988 Dec; 78(6):1431-42.
      View in: PubMed
    269. Vallabhajosula S, Paidi M, Badimon JJ, Le NA, Goldsmith SJ, Fuster V, Ginsberg HN. Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. J Nucl Med. 1988 Jul; 29(7):1237-45.
      View in: PubMed
    270. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation. 1988 Jun; 77(6):1213-20.
      View in: PubMed
    271. Fuster V, Badimon L, Badimon JJ, Chesebro J. Prevention of thromboembolism induced by prosthetic heart valves. Semin Thromb Hemost. 1988 Jan; 14(1):50-8.
      View in: PubMed
    272. Badimon L, Turitto V, Rosemark JA, Badimon JJ, Fuster V. Characterization of a tubular flow chamber for studying platelet interaction with biologic and prosthetic materials: deposition of indium 111-labeled platelets on collagen, subendothelium, and expanded polytetrafluoroethylene. J Lab Clin Med. 1987 Dec; 110(6):706-18.
      View in: PubMed
    273. Badimon L, Badimon JJ, Rand J, Turitto VT, Fuster V. Platelet deposition on von Willebrand factor-deficient vessels. Extracorporeal perfusion studies in swine with von Willebrand's disease using native and heparinized blood. J Lab Clin Med. 1987 Nov; 110(5):634-47.
      View in: PubMed
    274. Adams PC, Fuster V, Badimon L, Badimon JJ, Chesebro JH. Platelet/vessel wall interactions, rheologic factors and thrombogenic substrate in acute coronary syndromes: preventive strategies. Am J Cardiol. 1987 Oct 30; 60(12):9G-16G.
      View in: PubMed
    275. Badimon L, Badimon JJ, Turitto VT, Fuster V. Role of von Willebrand factor in platelet interaction with an expanded PTFE surface. ASAIO Trans. 1987 Jul-Sep; 33(3):621-5.
      View in: PubMed
    276. Fuster V, Adams PC, Badimon JJ, Chesebro JH. Platelet-inhibitor drugs' role in coronary artery disease. Prog Cardiovasc Dis. 1987 Mar-Apr; 29(5):325-46.
      View in: PubMed
    277. Badimon JJ, Fleming CR, Patton J, Mao SJ. Changes of plasma levels of apolipoproteins A-I, A-II, and B and their isoforms in patients with intestinal failure receiving long-term parenteral nutrition. Am J Clin Nutr. 1987 Feb; 45(2):414-22.
      View in: PubMed
    278. Badimon L, Badimon JJ, Turitto VT, Fuster V. Thrombosis: studies under flow conditions. Ann N Y Acad Sci. 1987; 516:527-40.
      View in: PubMed
    279. Adams PC, Badimon JJ, Badimon L, Chesebro JH, Fuster V. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty. Cardiovasc Clin. 1987; 18(1):49-71.
      View in: PubMed
    280. Galvez A, Badimon L, Badimon JJ, Fuster V. Electrical aggregometry in whole blood from human, pig and rabbit. Thromb Haemost. 1986 Oct 21; 56(2):128-32.
      View in: PubMed
    281. Badimon JJ, Kottke BA, Chen TC, Chan L, Mao SJ. Quantification and immunolocalization of apolipoprotein E in experimental atherosclerosis. Atherosclerosis. 1986 Jul; 61(1):57-66.
      View in: PubMed
    282. Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model. Arteriosclerosis. 1986 May-Jun; 6(3):312-20.
      View in: PubMed
    283. Badimon L, Steele P, Badimon JJ, Bowie EJ, Fuster V. Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs. Arteriosclerosis. 1985 Jul-Aug; 5(4):366-70.
      View in: PubMed
    284. Fuster V, Lie JT, Badimon L, Rosemark JA, Badimon JJ, Bowie EJ. Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease. Arteriosclerosis. 1985 Jan-Feb; 5(1):67-73.
      View in: PubMed
    285. Patton JG, Badimon JJ, Mao SJ. Monoclonal antibodies to human plasma low-density lipoproteins. II. Evaluation for use in radioimmunoassay for apolipoprotein B in patients with coronary artery disease. Clin Chem. 1983 Nov; 29(11):1898-903.
      View in: PubMed
    286. Mao SJ, Patton JG, Badimon JJ, Kottke BA, Alley MC, Cardin AD. Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of 125I-labeled low-density lipoproteins by combined use of two monoclonal antibodies. Clin Chem. 1983 Nov; 29(11):1890-7.
      View in: PubMed
    287. Hernández MR, Villaverde CA, Padró MT, Badimon JJ, Valdecasas FG. [Mesenteric microthrombosis: a new method for the study of injectable agents]. Arch Farmacol Toxicol. 1981 Apr; 7(1):35-8.
      View in: PubMed
    Badimon's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067